Significant Findings and What They Mean To put it into perspective, for every 1,000 patients treated over a year, there were nine fewer cardiovascular deaths and 10 fewer cardiovascular events in those on GLP-1 medications
HCC due to chronic hepatitis B virus (HBV) or C virus (HCV) infection has decreased due to universal vaccination for HBV and effective antiviral therapy for both HBV and HCV, but HCC related to metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease is increasing
The menus are easily searchable, so you can find what you need without much effort
entecavir-based regimens: individual patient data meta-analysis
Transitioning from other compounds Researchers switching from tirzepatide to retatrutide should be aware that they may experience a noticeable increase in heart rate effects due to the addition of glucagon receptor activation
Since 2020, the number of prescriptions made for these drugs has tripled, and its estimated that 12% of Americans have used these medications
